Vaccine maker Bharat Biotech International and the University of Sydney Infectious Diseases Institute (Sydney ID) have signed an MoU to advance vaccine research initiatives, strengthen academic-industry partnerships and augment global efforts to combat infectious diseases.
The agreement aims to build strong sectoral and cross-organisational collaborations to design novel methodologies to tackle future epidemics and infectious diseases. The intent is to also leverage academia-industry strengths for advancing the science of vaccines and biotherapeutics, Bharat Biotech said in a release on Tuesday.
“Mutually, we are excited about the new opportunities to strengthen our shared vision, leverage the prowess of education, research capabilities to help build a healthier universe and improve people’s lives by developing safer vaccine platforms,” Executive Chairman Krishna Ella said.
